The demand for pharmaceuticals continues to grow with the import and export of medical devices. Domestic pharmaceutical innovation and R&D are constantly improving, but due to differences in production equipment, technology, and R&D capabilities, there are differences in efficacy between domestic and imported drugs, which temporarily cannot meet the needs of the people for medicine. So let's take a look at China's Medical Device Import and Export trade structure analysis!

　　As a new format that reshapes the global supply chain system, cross-border e-commerce can help domestic people obtain a wide variety of price-preferential goods. During the "14th Five-Year Plan" period, cross-border e-commerce channels will be used to address the difficulty of "buying medicine" for domestic patients.

　　First, improve the regulatory system for the import of pharmaceuticals via cross-border e-commerce. Pharmaceuticals are different from other commodities, and attaching importance to the safety of imported pharmaceuticals is a guarantee of people's lives and health. Cross-border e-commerce import of pharmaceuticals should establish a traceable system for origin tracking and full process traceability to prevent counterfeit and substandard pharmaceuticals from entering the country, and at the same time, implement tiered management of prescription drugs to ensure orderly circulation of cross-border pharmaceuticals.

　　Second, strengthen cooperation with countries along the "Belt and Road". Europe is a major pharmaceutical production and manufacturing base in the world, with a well-developed regional pharmaceutical industry and is one of the important sources of pharmaceutical imports to China. We should make full use of the good economic and trade cooperation relations between China and the countries along the "Belt and Road", explore the advantages of the China-Europe freight train and European shipping routes, and further expand cooperation between China and Europe in the pharmaceutical industry.

　　Grasp Medical Device Import and Export development opportunities, strengthen innovation and research and development, and expand export scale

　　In 2020, China's medical device import and export structure was optimized and adjusted, achieving a shift from a deficit to a surplus. China will continue to seize the common and long-term opportunities of the fight against the epidemic, optimize and improve medical device production and manufacturing capabilities, expand export scale, and seize international market share.

　　First, increase efforts in innovation and R&D to achieve domestic substitution of high-end equipment. In the field of high-end medical devices, China still relies on imports to some extent. Currently, the epidemic situation abroad is still severe, and world productivity is in the recovery stage. Under the favorable situation of domestic epidemic control, it is necessary to strengthen the innovation and R&D of medical devices to replace high-end medical devices domestically.

　　Second, build the international influence of the "Made in China" brand and expand the export scale. In 2020, China's medical device exports grew rapidly, which is a reaffirmation of China's manufacturing by the international community. However, the brand influence of China's pharmaceutical products in the international community is still insufficient. In the face of the severe situation of the global COVID-19 epidemic, this is both a challenge and an opportunity. Made in China must always maintain high-quality standards, strengthen the promotion of China's medical device brands, and achieve more pharmaceutical brands going global.

　　The above is an introduction to China's Medical Device Import and Export trade structure analysis. For more information, please feel free to contact us!